Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T16:52:50.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates regarding a Phase 1b clinical study involving DS-8201a and pembrolizumab for advanced breast cancer and NSCLC, with new identifiers and collaborators added, while extensive details about the study's design and inclusion criteria have been removed.
    Difference
    32%
    Check dated 2025-04-23T15:33:15.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 24, 2025. However, the removal of the date March 25, 2025, indicates a potential change in scheduling or availability.
    Difference
    0.3%
    Check dated 2025-04-09T08:55:43.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release, moving from Revision v2.14.2 to v2.14.3, with the last update date changed from February 24, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:09:45.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The reference to 'AstraZeneca UK Limited' has been removed, while 'AstraZeneca' remains mentioned on the page.
    Difference
    0.1%
    Check dated 2025-03-03T23:26:38.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has been updated to reflect that the study is now active and not recruiting, with a total of 30 locations listed. Additionally, several past dates and contact information have been removed.
    Difference
    6%
    Check dated 2025-02-24T20:34:54.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.